Methylphenidat betydning for motorisk indlæring hos patienter med apopleksi
Phase 1
- Conditions
- Patients less that 2 months after the first hemorrhagic or ischemic stroke.
- Registration Number
- EUCTR2006-002554-29-DK
- Lead Sponsor
- Hammel neurocenter
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1. Less than two months after first ischemic or hemorrhagic stroke.
2. Moderate to light hand paralysis
3. Able to read and understand the written information
4. Signed informed consend
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1. Epilepsy
2. Glausoma
3. Hyperthyroidisme
4. Cardiac arytmia
5. Known heart disease or angina.
6. Metal implants
7. Pacemaker
8. Pregnancy
9. Diastolic BP>100 mmHg
10. In treatment with MAO-inhibitor, SSRIs og Ritalin
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method